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Abstract
Imprinted genes display parent-of-origin-specific expression with this epigenetic system of regulation found exclusively in 
therian mammals. Historically, defined imprinted gene functions were almost solely focused on pregnancy and the influence 
on the growth parameters of the developing embryo and placenta. More recently, a number of postnatal functions have been 
identified which converge on resource allocation, both for animals in the nest and in adults. While many of the prenatal func-
tions of imprinted genes that have so far been described adhere to the “parental conflict” hypothesis, no clear picture has yet 
emerged on the functional role of imprints on postnatal metabolism. As these roles are uncovered, interest in the potential for 
these genes to influence postnatal metabolism and associated adult-onset disease outcomes when dysregulated has gathered 
pace. Here, we review the published data on imprinted genes and their influence on postnatal metabolism, starting in the 
nest, and then progressing through to adulthood. When observing the functional effects of these genes on adult metabolism, 
we must always be careful to acknowledge the influence both of direct expression in the relevant metabolic tissue, but also 
indirect metabolic programming effects caused by their modulation of both in utero and postnatal growth trajectories.
Keywords Metabolic programming · Mouse models · Maternal care · Environment · Diet · Obesity
Introduction
Genomic imprinting is an epigenetic phenomenon resulting 
in parent-of-origin-specific gene expression [1–3] in the-
rian mammals. Pioneering experiments using parthenoge-
netic and androgenetic embryos demonstrated an absolute 
requirement for both of the parentally inherited genomes, 
implicating a genetic imbalance between the two and paving 
the way for the subsequent discovery of imprinted genes. 
Currently, around 150 genes have been demonstrated as 
imprinted and they show a large degree of overlap between 
mice and humans. Many of these are found in genomic 
clusters, each with an epigenetically regulated imprinting 
control region (ICR) [4, 5] that is, in effect, a differentially 
methylated region (DMR). Epigenetic marks including DNA 
methylation (at CpG dinucleotides, often found in clusters 
or CpG ‘islands’) and histone tail modifications (found at 
promoters or gene bodies), are initiated in the germline dur-
ing development and maintained in the developing embryo 
and throughout postnatal lifespan. Most imprinted loci have 
been demonstrated to possess multiple layers of epigenetic 
control allowing appropriate expression of the active, but 
not silent allele. These mechanisms of regulation are beyond 
the scope of this article and have been extensively reviewed 
previously [6–9].
The development and subsequent expansion of the 
imprinting system may have evolved as a consequence of 
‘parental conflict’ in response to selective pressures uniquely 
encountered by a pregnancy. This hypothesis [10] suggests 
a difference in the interests of the maternal and paternal 
genome, whereby females, who are related to all of her off-
spring, aim to conserve maternal resources over multiple 
litters and pups. In contrast, with possible multiple paternity 
across litters, and therefore as it is not necessarily related 
to other offspring of the mother, the opportunistic pater-
nal genome seeks to extract maximal maternal resources. 
In keeping with this hypothesis, paternally expressed genes 
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(PEGs) are generally growth promoting, whereas mater-
nally expressed genes (MEGs) are growth restricting [11]. 
A second hypothesis, the co-adaptation model of genetic 
symbiosis between mother and offspring, has also been 
proposed [12]. This suggests that monoallelic expression 
of imprinted genes arose to achieve maximal efficiency of 
offspring development, via maternal care inputs and also 
directly in the offspring, and is discussed later in more detail. 
However, as our knowledge of imprinted gene function has 
expanded, we have observed an increasing number of “out-
lier” imprinted genes which do not obviously fit within these 
expected patterns, suggesting that other evolutionary pres-
sures beyond conflicting parental genomes or co-adaptation 
have led to the broadening of this method of gene regula-
tion. Interestingly, this method of gene dosage control is not 
exclusively a mammalian phenomenon, with evolutionary 
isolated systems having been observed in plants and pos-
sibly birds [13, 14]. Alongside X-chromosome inactivation, 
a distinct form of regulating appropriate dosage from the 
sex chromosomes in mammals, these methods of epigenetic 
regulation, whether silencing an allele or chromosome, pre-
sumably provide an advantageous phenotype, regardless of 
any perceived dangers associated with functionally possess-
ing monoallelic rather than biallelic genes, i.e. masking of 
deleterious mutations.
Monoallelic imprinted genes are therefore subject to vul-
nerability in terms of gene dosage not normally encountered 
by non-imprinted loci, highlighted by the fact that altered 
imprinted gene expression is associated with a wide range 
of human disorders that can be modelled with specific gene 
modifications in mice. Prader–Willi, Angelman, Silver–Rus-
sell, Beckwith–Wiedemann syndromes and transient neo-
natal diabetes all result from abnormalities in the expres-
sion of specific imprinted genes (reviewed in [15, 16]). 
With the likely exception of Angelman syndrome, believed 
to be caused exclusively by the loss of expression of the 
UBE3A gene, many of these so-called imprinting disorders 
arise as a result of altered expression of a cluster of genes 
sharing the same epigenetic control, with consequent loss of 
expression or increased dosage of affected genes. Consistent 
with the roles of imprinted genes in key processes such as 
growth, metabolism and behaviour, these disorders result 
in a range of clinical features including aberrant pre- and/
or postnatal growth, abnormal feeding behaviour, learning 
difficulties and metabolic complications [16]. Discovery of 
these genetic modifications, and the conditions associated 
with them, has led to the necessary task of picking apart the 
individual contributions of various genes in these clusters, 
made more difficult by the intrinsic epigenetic mechanisms 
in place regulating imprinted (and non-imprinted) genes 
across the same genomic region. Even so, the clinical fea-
tures described in patients with these conditions are gener-
ally consistent with those observed in mouse models.
Although imprinted genes display a variety of cellular 
roles (cell cycle control, ion channels, protein synthesis 
and degradation and nutrient transport), their expression 
frequently shares common features of having maximal lev-
els during the prenatal and/or postnatal period, and occur-
ring predominantly in tissues governing resource allocation 
(brain, placenta, adipose tissue and pancreatic beta cells). 
It is, therefore, not surprising that a substantial number 
of imprinted genes are critical for placental function and 
normal fetal growth and development [17–20]. These roles 
extend to a wide range of processes vital for survival and 
development postnatally, including thermoregulation, feed-
ing behaviour and regulation of glucose and lipid metabo-
lism [21–31].
To understand these diverse roles, a number of different 
approaches have been employed to study imprinted genes 
and their function. Standard constitutive deletion models 
provide key insights into gene function and have been criti-
cal for identifying intrinsic roles of imprinted genes in regu-
lating metabolism. However, they are limited by the nature 
of imprinted genes, whereby heterozygous mutations pre-
sent as functionally null and are frequently associated with a 
wide range of both developmental and adult pathologies, and 
with at least some degree of mortality. In a distinct approach 
from more standard gene deletion models that target the 
coding region of a gene, a number of mouse models have 
been generated whereby the ICR, where differential meth-
ylation is normally found, is deleted. These deletions have 
often been designed to mimic those changes seen in human 
disease, with the resulting absence of epigenetic marks 
modulating the expression of some or all the genes within 
an imprinted cluster, producing both loss of expression and 
loss of imprinting (biallelic expression) within the affected 
cluster [32, 33]. Transgenic mouse lines, whereby additional 
copies of imprinted genes are expressed from a vector such 
as a bacterial artificial chromosome (BAC), allow the con-
sequences of elevating imprinted gene dosage to be studied. 
Thus, modeling ‘loss of imprinting’ can frequently be used 
to elegantly contrast with loss of expression observations. 
Limitations to this approach centre on the already discussed 
complexities associated with multiple layers of epigenetic 
control and the chromosomal clustering of these genes. As 
a result, expression from these transgenes often only loosely 
recapitulates endogenous expression, due in part to missing 
distant regulatory elements on the vector, and altered expres-
sion of some, but not all genes found within an imprinted 
cluster. Furthermore, it should be noted that monoallelic 
expression and tissue distribution of certain imprinted 
genes, i.e. Grb10/GRB10 are not always similarly regulated 
in mice and humans [34–38]. That being said, these genetic 
approaches in mice have been instrumental in identifying 
roles for a number of imprinted clusters and are generally 
at their most persuasive when used in conjunction with one 
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another, to provide a more complete picture of specific gene 
function within an imprinted cluster.
As previously mentioned, perhaps the most prominent 
feature of imprinted genes is their relative enrichment of 
expression in fetal and placental tissue and their potency 
for modulating in utero growth potential. Abnormal growth 
and development in these early prenatal and/or postnatal 
periods due to genetic (imprinted gene mis-expression) or 
environmental causes (such as reduced or excessive nutrient 
availability) are itself strongly associated with the risk of 
developing metabolic disease in later life [39, 40]. This phe-
nomenon is both interesting in a biological sense and also 
strongly influences how we assess adult metabolic health. 
However, it adds another layer of complexity to studying 
the function of imprinted genes and their contribution to 
the effects observed upon their deletion. Without the use 
of inducible imprinted gene deletion, it is difficult to distin-
guish whether metabolic phenotypes arising in adulthood 
are due to alterations in growth and developmental in early 
life, or whether the absence of imprinted gene expression is 
sufficient to drive metabolic phenotypes in adulthood alone. 
Here, we will discuss the current understanding of imprinted 
genes and their physiological importance, with an emphasis 
on their contribution to growth and metabolism at various 
stages of postnatal mammalian lifespan.
Control of fetal growth and placental 
resources
Although this review will focus on the influence of 
imprinted genes on growth and metabolism after birth, it 
is important to at least mention the contribution of these 
genes in utero. A crucial structure in mammalian prenatal 
development, the placenta acts as a boundary between the 
mother and the developing fetus and is essential for hormone 
transport, immunity to environmental pathogens and as a 
source of nutrients and growth factors. A significant num-
ber of imprinted genes are expressed in the placenta itself, 
with the importance of their dosage in the placenta demon-
strated by the finding that loss of function or loss of imprint-
ing of several genes causes severe placental abnormalities 
and subsequent fetal growth defects or even lethality. For 
example, disruption of placental Ascl2, Phlda2 or Cdkn1c 
results in placental structural abnormalities and perturbed 
placental and fetal growth [41–46]. Other imprinted genes 
modulate fetal growth via an effect in both placental and 
embryonic tissues including Grb10 and Dlk1 [47–51] as well 
as the Igf2 and Igf2r system [52–54]. In this latter example, 
dual growth promoting effects from placenta and fetus were 
demonstrated by the fact that fetal growth restriction caused 
by placental-specific knockout of Igf2 was worsened upon 
global deletion of Igf2 [55]. These in utero interactions have 
been reviewed in detail [15, 20, 56] and so herein we will 
focus on the effects of imprinted gene expression on modu-
lating growth and metabolism from birth onwards.
Thriving in the neonatal nesting period
Imprinted gene expression frequently extends into the neo-
natal and postnatal stages, regulating growth and metabo-
lism after birth. This stage of life represents a period when 
there is a necessity for a combination of both behavioural 
actions from the pup, with its demand for nutrients (from the 
mother’s milk) to enable both growth and the rapid laying 
down of fat stores, and also to keep warm in the nest prior 
to full independent thermoregulation. On the other hand, 
maternal instincts that allow sufficient nurturing of the new-
born (feeding, milk production, nest building) are of equal 
importance. Again, here, imprinted genes are at the centre 
of this crucial phase of life, and are discussed below (also 
see Fig. 1 for summary).
Offspring thermoregulation and feeding behaviour
Discussed below are some of the contributions of imprinted 
gene function based on either metabolic or behavioural 
effects in the neonatal period (Fig. 1). In the pup, deletion 
of exon 1 at the Gnas locus and disruption of XLas in the 
same cluster lead to impaired suckling, resulting in high neo-
natal lethality [23]. Similarly, paternal disruption of Magel2 
results in reduced postnatal viability with reduced appetite 
and a failure to suckle [24, 57, 58]. Also intrinsic to the 
pup, deletion of the paternally expressed gene Peg3 renders 
them chronically hypothermic and less able to defend their 
body temperature under cold challenge [59]. Disruption or 
overexpression of the paternally expressed gene Dlk1 results 
in fetal and postnatal growth restriction or overgrowth, 
respectively, with both genetic manipulations associated 
with partial neonatal lethality [50, 51]. Also found at this 
locus, and controlled by the same shared ICR, disruption of 
the paternally expressed gene Dio3 leads to partial embry-
onic lethality and is associated with thyrotoxicosis [60, 61]. 
Postnatally, disruption of the ICR at this cluster that modi-
fies both Dlk1 and Dio3 dosage, amongst others, impacts 
upon the development of brown adipose tissue (BAT) and 
therefore appropriate control of thermogenesis outside of 
the nest and subsequent postnatal survival [26]. Huddling 
for warmth is a simple cooperative behaviour observed in 
many species, in which the costs of heat production are 
borne by the individual but the benefits are shared. Under the 
paternal conflict theory, maternally expressed genes would 
favour increased thermogenic contribution, while pater-
nally expressed genes would act to restrict this process, and 
although some imprinted genes hold firm to this (Grb10, 
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Cdkn1c and Dlk1) [26, 29, 62], exceptions to this trend have 
been observed (Peg3) [59].
Maternal–fetal interactions and the co‑adaptation 
model
Paternally expressed genes Peg1 (Mest) and Peg3 are 
strongly expressed in the developing postnatal brain and, 
when mutated, result in compromised maternal care in 
mutant nursing mothers. Specifically, this includes reduced 
nest building and pup care with reduced maternal food intake 
and impaired milk letdown [21, 22, 63]. Disruption of either 
of these genes in the mother culminates in reduced pup sur-
vival, even if offspring are wild type and therefore display 
no other growth impairments. A large number of imprinted 
gene deletion models adhere to the parental conflict model, 
whereby ablation of paternally expressed genes leads to 
growth defects, while ablation of maternally expressed genes 
leads to early overgrowth. However, although a large portion 
of imprinted gene functions fit with this model, there are a 
significant number that do not clearly adhere to these rules, 
and this is particularly apparent when observing maternal 
care paradigms.
The co-adaptation model [12] puts forward the idea that 
genomic imprinting arose to establish a form of genetic 
symbiosis between mother and offspring, where imprinted 
gene function acts at both the level of the mother and in 
offspring interaction, with silencing of one copy able to 
benefit offspring vigor by modulating both organisms. This 
occurs with the imprinted gene Grb10, which is unique in 
the sense that it is maternally expressed in peripheral tissues 
but paternally expressed in the CNS under a brain-specific 
promoter [37, 48]. Accordingly, paternal uniparental disomy 
(UPD) or maternal Grb10 deletion results in prenatal and 
postnatal (~ 130%) overgrowth, but with a disproportionately 
small brain and large liver [47, 48, 64]. Additionally, these 
mutants display major physiological alterations in peripheral 
tissues including perturbed BAT-mediated thermogenesis, 
increased lean mass, reduced adiposity and improved glu-
cose metabolism [37, 62, 64–66]. Inversely, paternal Grb10 
expression within the CNS appears to be more important 
at the behavioural level, with paternal deletion resulting in 
increased social dominance [37]. Gene deletion studies also 
demonstrate the contribution of Grb10 expression in the 
mother and from the pup. Disruption of maternal Grb10 
expression in the pup appears to increase nutrient demand 
from the offspring, whereas maternal Grb10 deficiency in 
the mother prevents any increase in milk supply from the 
ducts (where Grb10 is also imprinted) under these condi-
tions of increased demand. Therefore, Grb10 regulates off-
spring growth and adiposity by mediating both sides of the 
mother–offspring interaction [67].
Post‑weaning catch up growth and adult metabolic 
complications
The transition to independent life involves crucial physi-
ological requirements such as maintaining core body tem-
perature outside of the nest, as described above. This post-
natal period also requires the offspring to begin to acquire 
food other than that provided by their mother, with concomi-
tant impacts upon the regulation of their metabolism. This 
requires a major metabolic shift, as the pup transfers from a 
lipid-rich milk-based source of nutrients from its mother, to 
a carbohydrate-rich diet [26, 68]. This shift from a generally 
lipolytic metabolism to a lipogenic one coincides with the 
Fig. 1  Surviving the neonatal 
nesting period requires multiple 
behavioural and metabolic 
inputs from both mother and 
pup. PEGs and MEGs that are 
functionally relevant to each 
process are displayed in green 
and red, respectively
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deposition of white adipose tissue (WAT) in the postnatal 
period (Fig. 2). Insulin, a key anabolic hormone required for 
sufficient adipose tissue accumulation, plays a more impor-
tant role in the postnatal rather than prenatal period in mice. 
This is demonstrated by the fact that deletion of both major 
forms of insulin in rodents, Ins2 (imprinted during the ges-
tational period but with biallelic expression postnatally) and 
Ins1 (non-imprinted), or ablating the insulin receptor Insr, 
does not cause any major growth or metabolic perturbations 
to glucose homeostasis in utero. However, these mutants 
develop rapid neonatal diabetes soon after birth [69–72].
The paternally expressed imprinted gene, Plagl1, is 
located in a genomic region associated with transient neo-
natal diabetes in humans, caused by either paternal UPD of 
chromosome 6 or duplication of this region [73]. This effect 
is phenocopied in mice with overexpression of Plagl1, recre-
ating this neonatal hyperglycaemia observed in affected chil-
dren [74]. Similarly, Rasgrf1 is a paternally expressed gene 
found primarily in the postnatal brain and pancreatic beta 
cells. Mice null for Rasgrf1 on the paternal allele are post-
natally growth restricted which continues into adulthood. 
In adulthood they also present with hypoinsulinaemia from 
reduced beta cell mass (due to reduced beta cell neogenesis 
and proliferation) and, therefore, demonstrate impaired glu-
cose tolerance [75, 76].
Abnormal growth in the postnatal period (Fig. 2), due 
to genetic or environmental causes (such as reduced or 
excessive nutrient availability), influences key processes 
governing feeding and energy homeostasis in early adult-
hood. As such, these defects are strongly associated with 
the risk of developing obesity and metabolic disease in 
late adulthood [39, 40, 77]. This occurs when a developing 
organism responds to substandard environmental conditions 
during early stage programming. Ultimately, this leads to 
an increased risk of developing the metabolic syndrome in 
later life, a phenomenon known as metabolic programming 
that falls within the wider phenomena of fetal programming 
[78, 79] (Fig. 2; Table 1). Proposed mechanisms for how this 
early life adversity can be detrimental to long-term meta-
bolic health include permanent changes in organ structure 
and programmed and sustained epigenetic changes in gene 
expression [80, 81]. Altered imprinted gene dosage for vari-
ous paternally expressed genes is, therefore, a risk factor for 
obesity in adulthood. Deficiency of Ndn or overexpression 
of Peg1 (Mest) in mice causes obesity owing to increases 
in adipose tissue expansion [82–84]. Brain-specific dele-
tion of Gsa, which controls melanocortin-mediated energy 
expenditure in the hypothalamus, results in hypometabolism 
and obesity with associated glucose intolerance and insu-
lin resistance [25, 85–87]. There are, however, cases where 
failure to thrive in the postnatal period does not necessarily 
lead to obesity and the metabolic syndrome in adulthood. 
Pups with disruption of XLas that survive to adulthood are 
severely growth restricted, lean, with an increased metabolic 
rate and are hypersensitive to insulin, and display an associ-
ated hyperphagic phenotype [23, 28]. Similarly, although 
Fig. 2  Progression to independent postnatal life requires adequate development and functionality in multiple metabolic systems. Furthermore, 
restricting growth and development at this crucial early stage results in metabolic programming and thus metabolic complications in adulthood
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maternal duplication and, therefore, biallelic expression 
of Cdkn1c in mice phenocopies Silver–Russell Syndrome 
with low birth weight and neonatal hypoglycaemia, these 
early defects result in leanness in adults, due principally to 
browning of WAT. These animals are also protected from 
diet- and age-induced obesity, and the associated worsen-
ing of glucose tolerance and insulin sensitivity. A specific 
role for modulation of the brown adipocyte lineage is also 
implicated in Cdkn1c loss of function studies, with the null 
mice displaying a failure of BAT formation [29, 88].
Overall, these mouse models with altered expression 
of imprinted genes demonstrate a failure to thrive in the 
early postnatal period, mimicking the pattern observed in 
human imprinting disorders such as Prader–Willi and Sil-
ver–Russell syndrome [89, 90] (summarised in Table 1). 
A common feature of these early defects is a postnatal 
‘catch up’ growth phase following this failure to thrive 
period. Nnat (Peg5) is not expressed in the placenta and 
does not alter fetal growth, but its deletion causes a post-
natal growth restriction and subsequent catch up growth 
following weaning [30]. This catch up growth acts to re-
establish the growth of an organism back to its ‘normal’ 
trajectory (reviewed in [39]) and is frequently found after 
manipulation of imprinted gene dosage in mutant mice, 
often in the neonatal and/or postnatal period, where mice 
are transitioning to leaving the nest (reviewed in [15]). In 
adulthood, Nnat null mutants have lower energy expendi-
ture and are hypoactive, leptin resistant and hyperphagic, 
which together lead to the development of obesity [30]. 
Obesity also results from deletion of paternally expressed 
genes Peg3, Dlk1 or Magel2, with differences in feeding 
and energy expenditure, all of which exhibit early post-
natal catch up growth in the null allele of each gene [24, 
51, 57, 59]. Magel2 mutation is associated with a post-
natal failure to thrive, with pups that reach weaning age 
developing obesity and hyperinsulinaemia, with associated 
reduced energy expenditure, even in the face of hypopha-
gia and hypoactivity [57, 58, 91, 92]. Although display-
ing reduced survival as pups, Peg3 null mice that survive 
to early adulthood are underweight and hypophagic with 
delayed postnatal adipose deposition, but with elevated 
adiposity in later life. This is due to hypothalamic dys-
regulation manifesting as reduced metabolic rate and core 
body temperature and also leptin resistance [59, 63]. Mice 
with altered expression of Dlk1 have postnatal growth 
defects with partial lethality [49, 51]. Mutant mice surviv-
ing until weaning demonstrate postnatal catch up growth 
and increased adiposity on both normal and high fat diet 
[49, 51]. Conversely, mice with transgenic Dlk1 overex-
pression, although displaying increased prenatal growth, 
also show partial lethality due to major organ abnormali-
ties [50]. Surviving adults, however, have reduced adult 
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adiposity and resistance to high fat diet, with improved 
glucose tolerance and insulin resistance [93].
Imprinted gene modulation in response 
to the environment
Our increased understanding of imprinted genes has 
revealed a multitude of functions that extend beyond 
the in utero period, regulating growth potential, resource 
allocation and metabolism from an early stage embryo 
through to adulthood and into later life. Primary epige-
netic marks, including differential DNA methylation of the 
ICRs that regulate imprinted genes, are laid down in the 
respective germlines and maintained throughout lifespan 
of the individual. While these marks are believed to initi-
ate monoallelic expression, secondary imprinting marks, 
which can also include DNA methylation but extend to 
modification of histone tails and chromatin architec-
ture, are established post-fertilisation and are thought to 
help retain the correct expression of the gene or cluster. 
It has been shown in numerous experiments that epige-
netic marks can be susceptible to environmental modu-
lation [94–101]. One could, therefore, hypothesize that 
imprinted genes would be environmentally sensitive as a 
group, due to the requirement of these epigenetic marks to 
ensure appropriate allelic expression. These marks are laid 
down in utero, either via the methylation of the ICRs in the 
newly formed germ cells of the embryo, or via secondary 
imprinting marks in the developing somatic tissues. This 
would, therefore, suggest that the in utero period provides 
a key window for environment-dependent programming of 
imprinted gene expression.
An early study into this potential sensitivity showed that 
the ICRs as a group were insensitive in offspring that had 
been exposed to gestational protein restriction [102]. The 
authors did, however, note that there were some modest 
changes in the expression of those imprinted genes ana-
lysed. More recently, studies have shown that the putative 
secondary imprinting marks may in fact show some envi-
ronmental sensitivity [94]. The clearest indication of this 
response was demonstrated by a new approach to studying 
imprinted genes, where a firefly luciferase knock-in model 
was used to image allelic expression of the Cdkn1c gene. 
Upon gestational low protein exposure, a loss of imprint-
ing occurred whereby exposed embryos were found to have 
active transcription of the Cdkn1c gene from both of the 
parentally inherited alleles, which was retained into adult-
hood. These changes were found to be caused by gesta-
tional erosion of differential DNA methylation of a region 
spanning the Cdkn1c promoter, a secondary imprinting 
mark that usually retains silencing of the paternal allele. 
Perhaps most interestingly, these changes could be largely 
buffered against by the supplementation of dietary folate, 
indicating that the limited availability of dietary methyl 
donors was the cause of these epigenetic changes [94].
While studies have shown that as a group imprinted genes 
show no specific responsiveness to environmental modu-
lation [103], it remains most likely that certain imprinted 
loci are sensitive to specific stimuli. The reasons for this 
selective sensitivity, or the phenotypic consequences of the 
resulting expression changes, are not currently understood. 
However, the different mouse models of imprinted gene 
modulation that have so-far been discussed would suggest 
that any changes are likely to be profound and lifelong. A 
recent study using haploinsufficiency of the epigenetic modi-
fier Trim28 demonstrated that imprinted gene dysregulation 
can provide a clear indicator of metabolic fitness, and these 
observations appeared to be closely re-capitulated in cohorts 
of obese children [104]. It should also be noted that due 
to the unique epigenetic regulation that imprinted genes 
undergo, with the establishment of methylation marks in 
the developing germlines, any sensitivity of these marks to 
environmental pressures in pregnancy has the potential to 
directly influence both the F1 and F2 generations. However, 
studies concerning multi-generational and trans-generational 
effects on imprinted genes have, until now, provided some-
what conflicting data [105–109]. The extent of environmen-
tal sensitivity of this group of genes will only truly be estab-
lished through further well-controlled studies.
Concluding remarks
Imprinted genes function in multiple cellular pathways 
but their roles appear to converge on postnatal processes 
that modulate early growth and behaviour. Unsurprisingly, 
genetic deletion in mice has proved to be a major source of 
knowledge in terms of imprinted gene function (Table 1), 
although the organisation of imprinted genes into genomic 
clusters often makes the design or analysis of these mutant 
mouse models difficult. However, these null alleles have 
been crucial to our understanding of imprinted gene func-
tion. Transgenic models expressing more than one active 
allele and, therefore, modelling loss of imprinting often 
results in severe phenotypic outcomes and so provide evi-
dence for the evolutionary impetus behind the reduced dos-
age of imprinted genes in a particular organism. Imprinted 
genes are expressed in the fetus and placenta during gesta-
tion and, clearly, are important for placental function and 
embryonic growth [1–3]. The fact that the development 
of genomic imprinting appears to have coincided with the 
appearance of the placenta in evolution strongly suggests 
an interrelated role for both the regulation of the supply and 
demands of nutrients in utero [5, 11, 110]. However, it has 
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also been suggested that genomic imprinting arose as a result 
of co-adaptation between the mother and her offspring to 
achieve optimal fitness for both via placental resource allo-
cation in utero and via lactation in the nesting period [12, 
111].
Without information from inducible deletion mouse mod-
els, where imprinted gene expression is retained in early life 
and deleted in adulthood, it has been challenging to tease 
apart the relative contributions of imprinted genes in early 
life and adulthood. However, as has been described, a grow-
ing number of direct functional roles have been assigned 
to imprinted gene expression in adult metabolic tissues. 
Whether there is added evolutionary impetus for genes to be 
imprinted as they affect adult metabolism either directly or 
indirectly remains unclear. Certainly, it can be said that using 
current hypotheses for why imprinting arose in mammals, 
it is challenging to explain many of the observed effects in 
adult tissues of transgenic mice. It remains likely that the 
initial driving force for the appearance of the imprinting 
system arose alongside the emergence of the mammalian 
pregnancy, and not due to any potential benefits observed in 
adult tissue. That is not to say that evolutionary pressure cen-
tering on adult metabolic tissues has not been a key driving 
force for the subsequent expansion of the imprinting system 
that has occurred with the mammalian phylogenic evolution.
Failure to thrive in infancy leads to complications in 
adulthood (Table 1). The postnatal period requires a com-
bination of behavioural (suckling for milk) and metabolic 
(independent thermoregulation) actions in the offspring 
as well as sufficient maternal care (feeding, milk produc-
tion, nest building), with imprinted genes central to these 
processes. Postnatal offspring are then required to begin 
to seek food other than that provided by their mother and 
subsequently shift their internal metabolism to a lipogenic 
directionality, coinciding with an increase in adipose tissue 
stores. A failure to thrive in this crucial period, marked by 
phenotypic features such as postnatal growth restriction and 
early metabolic defects, permanently alters developmental 
trajectories in the offspring. These alterations in fat deposi-
tion and hypothalamic circuitry lead to metabolic complica-
tions in the adult, often in the form of obesity, as a direct 
result of phenotypes such as hyperphagia, reduced energy 
expenditure and leptin resistance. Ultimately, obesity is 
the cause of multiple secondary metabolic disorders in the 
periphery such as reduced glucose uptake and insulin resist-
ance. However, a restriction to proper adipose expansion is 
itself a driver of the metabolic syndrome, as the inability to 
store potentially toxic lipids in inert adipose tissues leads to 
their deposition in more sensitive peripheral organs includ-
ing muscle and liver [112].
An array of metabolic disorders stems from inappropriate 
expression levels of imprinted genes [85, 89, 90, 113–117]. 
With a greater understanding of imprinted gene function, we 
are now beginning to see that these effects are both indirect, 
through early life programming, and direct in adult tissues, 
with subtle modulations in expression capable of inducing 
profound phenotypic consequences. Imprinted genes, there-
fore, present as an interesting and novel target for pharma-
ceutical intervention in metabolic disease. Due to their well-
characterised epigenetic regulation, targeted therapies have 
the potential to “reprogramme” desired tissues, with early 
studies indicating great potential for this route [118]. As 
more functional roles are uncovered, so the interest in this 
group of genes will continue.
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